HuGE Literature Finder
|
||
Records 1-35
|
Lack of evidence for a liver or intestinal miRNA regulation involved in the hypertriglyceridemic effect of APOC3 3'UTR variant SstI.
Atherosclerosis 2016 Dec 255 6-10. Dancer Marine, Caussy Cyrielle, Di Filippo Mathilde, Moulin Philippe, Marçais Christophe, Charrière Syb |
|
Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population.
World journal of gastroenterology : WJG 2014 Oct 20 (38): 14010-7. Li Min-Rui, Zhang Sheng-Hong, Chao Kang, Liao Xian-Hua, Yao Jia-Yan, Chen Min-Hu, Zhong Bi-H |
|
Genetic score based on high-risk genetic polymorphisms and early onset of ischemic heart disease in an Italian cohort of ischemic patients.
Thrombosis research 2014 May 133 (5): 804-10. Vecoli Cecilia, Adlerstein Daniel, Shehi Erlet, Bigazzi Federico, Sampietro Tiziana, Foffa Ilenia, Carpeggiani Clara, L'abbate Antonio, Andreassi Maria Graz |
|
Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population.
Lipids in health and disease 2014 13 170. Cui FengHe, Li KeZhong, Li YunFeng, Zhang XueWu, An ChangSh |
|
Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner.
Journal of the International AIDS Society 2014 17 (4 Suppl 3): 19557. Echeverría Patricia, Guardiola Montse, González Marta, Vallvé Joan Carles, Puig Jordi, Bonjoch Anna, Clotet Bonaventura, Ribalta Josep, Negredo Eugen |
|
Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease.
PloS one 2014 9 (6): e101082. van de Woestijne Anton P, van der Graaf Yolanda, de Bakker Paul I W, Asselbergs Folkert W, Spiering Wilko, Visseren Frank L J, |
|
Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.
Hepatology (Baltimore, Md.) 2012 Mar 55 (3): 781-9. Santoro Nicola, Zhang Clarence K, Zhao Hongyu, Pakstis Andrew J, Kim Grace, Kursawe Romy, Dykas Daniel J, Bale Allen E, Giannini Cosimo, Pierpont Bridget, Shaw Melissa M, Groop Leif, Caprio Son |
|
Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance.
Hepatology (Baltimore, Md.) 2011 Feb 53 (2): 467-74. Kozlitina Julia, Boerwinkle Eric, Cohen Jonathan C, Hobbs Helen |
|
Elevated levels of triglyceride and triglyceride-rich lipoprotein triglyceride induced by a high-carbohydrate diet is associated with polymorphisms of APOA5-1131T>C and APOC3-482C>T in Chinese healthy young adults.
Annals of nutrition & metabolism 2011 58 (2): 150-7. Lin Jia, Fang Ding Zhi, Du Juan, Shigdar Sarah, Xiao Li Ying, Zhou Xue Dong, Duan W |
|
Lack of association between apolipoprotein C3 gene polymorphisms and risk of coronary heart disease in a Han population in East China.
Lipids in health and disease 2011 10 (1): 200. Yu Juan, Huang Jingjing, Liang Yan, Qin Baodong, He Su, Xiao Jing, Wang Huimin, Zhong Renqi |
|
Effect of apolipoprotein C3 and apolipoprotein A1 polymorphisms on postprandial response to a fat overload in metabolic syndrome patients.
Clinical biochemistry 2010 Nov 43 (16-17): 1300-4. Clemente-Postigo M, Queipo-Ortuño M, Valdivielso P, Tinahones F J, Cardona |
|
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
The New England journal of medicine 2010 Mar 362 (12): 1082-9. Petersen Kitt Falk, Dufour Sylvie, Hariri Ali, Nelson-Williams Carol, Foo Jia Nee, Zhang Xian-Man, Dziura James, Lifton Richard P, Shulman Gerald |
|
[Correlation of metabolic syndrome clinical signs and genetic determinants at children with obese].
?ksperimental'nai?a i klinicheskai?a gastro?nterologii?a = Experimental & clinical gastroenterology 2010 (7): 6-11. Shcherbakova M Iu, Sinitsin P A, Poriadina G I, Larionova V I, Khmyrova A P, Petria?kina E E, Pronina L |
|
Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels.
Lipids in health and disease 2010 9 86. Ruixing Yin, Yiyang Li, Meng Li, Kela Li, Xingjiang Long, Lin Zhang, Wanying Liu, Jinzhen Wu, Dezhai Yang, Weixiong L |
|
A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia.
Human molecular genetics 2009 Nov 18 (21): 4189-94. Hegele Robert A, Ban Matthew R, Hsueh Neil, Kennedy Brooke A, Cao Henian, Zou Guang Yong, Anand Sonia, Yusuf Salim, Huff Murray W, Wang Ji |
|
The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.
European journal of human genetics : EJHG 2009 May 17 (5): 620-8. Henneman Peter, van der Sman-de Beer Femke, Moghaddam Payman Hanifi, Huijts Petra, Stalenhoef Anton F H, Kastelein John J P, van Duijn Cornelia M, Havekes Louis M, Frants Rune R, van Dijk Ko Willems, Smelt Augustinus H |
|
Common sequence variant in lipoprotein lipase gene conferring triglyceride response to fibrate treatment.
Pharmacogenomics 2009 Feb 10 (2): 267-76. Chien Kuo-Liong, Lin Yen-Lin, Wen Hui-Chin, Lin Hsing-Pei, Yen Ching-Tzu, Lin Shu-Wha, Kao Jau-Tsu |
|
Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
Pharmacogenetics and genomics 2009 Feb 19 (2): 161-9. Liu Yongjun, Ordovas Jose M, Gao Guimin, Province Michael, Straka Robert J, Tsai Michael Y, Lai Chao-Qiang, Zhang Kui, Borecki Ingrid, Hixson James E, Allison David B, Arnett Donna |
|
APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese.
Clinica chimica acta; international journal of clinical chemistry 2008 Apr 390 (1-2): 56-62. Chien Kuo-Liong, Fang Woei-Horng, Wen Hui-Chin, Lin Hsing-Pei, Lin Yen-Lin, Lin Shu-Wha, Wu June-Hsieh, Kao Jau-Tsu |
|
Prediction of genetic risk for dyslipidemia.
Genomics 2007 Nov 90 (5): 551-8. Yamada Yoshiji, Matsuo Hitoshi, Warita Shunichiro, Watanabe Sachiro, Kato Kimihiko, Oguri Mitsutoshi, Yokoi Kiyoshi, Metoki Norifumi, Yoshida Hidemi, Satoh Kei, Ichihara Sahoko, Aoyagi Yukitoshi, Yasunaga Akitomo, Park Hyuntae, Tanaka Masashi, Nozawa Yoshino |
|
Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.
Pharmacogenetics and genomics 2007 Sep 17 (9): 755-64. Arnedo Mireia, Taffé Patrick, Sahli Roland, Furrer Hansjakob, Hirschel Bernard, Elzi Luigia, Weber Rainer, Vernazza Pietro, Bernasconi Enos, Darioli Roger, Bergmann Sven, Beckmann Jacques S, Telenti Amalio, Tarr Philip E, |
|
Genetic epistasis in the VLDL catabolic pathway is associated with deleterious variations on triglyceridemia in obese subjects.
International journal of obesity (2005) 2007 Aug 31 (8): 1325-33. Brisson D, St-Pierre J, Santuré M, Hudson T J, Després J P, Vohl M C, Gaudet |
|
The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Atherosclerosis 2007 Apr 191 (2): 409-17. Martinelli Nicola, Trabetti Elisabetta, Bassi Antonella, Girelli Domenico, Friso Simonetta, Pizzolo Francesca, Sandri Marco, Malerba Giovanni, Pignatti Pier Franco, Corrocher Roberto, Olivieri Olivie |
|
Effect of SstI polymorphism of the apolipoprotein CIII gene and environmental factors on risks of hypertriglyceridemia in Taiwan aborigines.
Circulation journal : official journal of the Japanese Circulation Society 2006 Aug 70 (8): 1030-6. Huang Meng-Chuan, Wang Tsu-Nai, Liu Yi-Ling, Pa Te-Hsiung, Tu Hung-Ping, Huang Yi-Chia, Chang Wen-Tsan, Ko Ying-Ch |
|
Clinical and genetic associations with hypertriglyceridemic waist in a Canadian aboriginal population.
International journal of obesity (2005) 2006 Mar 30 (3): 484-91. Pollex R L, Hanley A J G, Zinman B, Harris S B, Hegele R |
|
Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
International journal of cardiology 2006 Jan 106 (2): 152-6. Dallongeville Jean, Cottel Dominique, Montaye Michèle, Codron Valérie, Amouyel Philippe, Helbecque Nico |
|
Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome.
Physiological research / Academia Scientiarum Bohemoslovaca 2006 55 (5): 483-90. Stancáková A, Baldaufová L, Javorský M, Kozárová M, Salagovic J, Tkác |
|
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
The Journal of infectious diseases 2005 May 191 (9): 1419-26. Tarr Philip E, Taffé Patrick, Bleiber Gabriela, Furrer Hansjakob, Rotger Margalida, Martinez Raquel, Hirschel Bernard, Battegay Manuel, Weber Rainer, Vernazza Pietro, Bernasconi Enos, Darioli Roger, Rickenbach Martin, Ledergerber Bruno, Telenti Amalio, |
|
Association of Sst I polymorphism in apolipoprotein C3 gene with hypertriglyceridaemia in coronary atherosclerotic heart disease and type II diabetes mellitus in Chinese population.
Yi chuan xue bao = Acta genetica Sinica 2005 Jan 32 (1): 11-8. Liu He-Kun, Li Xue-Fei, Zhang Si-Zhong, Ren Yan, Yong-Xin , Liu Yun-Qiang, Wang Chun-Ting, Chen Xiang, Hu Yao-Min, Zhang |
|
A single nucleotide polymorphism -1131T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese.
Molecular genetics and metabolism 2004 Nov 83 (3): 280-6. Bi Nan, Yan Sheng-kai, Li Guo-ping, Yin Zhi-nong, Chen Bao-she |
|
Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD.
Molecular and cellular biochemistry 2004 Apr 259 (1-2): 59-66. Chhabra S, Narang R, Lakshmy R, Vasisht S, Agarwal D P, Srivastava L M, Manchanda S C, Das |
|
Population prevalence of APOE, APOC3 and PPAR-alpha mutations associated to hypertriglyceridemia in French Canadians.
Journal of human genetics 2004 49 (12): 691-700. Garenc Christophe, Aubert Samuel, Laroche Jèrôme, Girouard Joël, Vohl Marie-Claude, Bergeron Jean, Rousseau François, Julien Pier |
|
Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians.
BMC genetics 2002 Jun 3 (): 9. Chhabra S, Narang R, Krishnan L R, Vasisht S, Agarwal D P, Srivastava L M, Manchanda S C, Das |
|
[Apolipoprotein C III gene Sst I polymorphism in patients with endogenous hypertriglyceridemia in Chinese population].
Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao / [bian ji zhe, Hua xi yi ke da xue xue bao bian wei hui] 2001 Jun 32 (2): 175-8, 190. Liu R, Bai H, Liu Y, Huang M, Liu |
|
Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst-I polymorphism, LPL mutations and apo E3 deficiency.
Diabetologia 2000 Nov 43 (11): 1346-52. Marçais C, Bernard S, Merlin M, Ulhmann M, Mestre B, Rochet-Mingret L, Revol A, Berthezene F, Moulin |
- Page last reviewed:Mar 1, 2018
- Page last updated:Jul 18, 2019
- Content source: